The following trial balance of Sheridan Company at December 31, 2025 has been properly adjusted. Sheridan Company Trial Balance December 31, 2025 Dr. Cr. Cash 876500 Accounts receivable (net) 2693000 Inventory 2086000 Property, plant, and equipment (net) 7572000 Accounts payable and accrued liabilities $ 1768000 Income taxes payable 656000 Deferred income tax liability 84500 Common stock 2351000 Additional paid-in capital 3677000 Retained earnings, 1/1/25 3518000 Net sales and other revenues 12848000 Costs and expenses 11160000 Income tax expense 515000 3 $24902500 $24902500 Other financial data for the year ended December 31, 2025: Included in accounts receivable is $1200000 due from a customer and payable in quarterly installments of $150000. The last payment is due December 29, 2025. During the year, estimated tax payments of $515000 were charged to income tax expense. The current and future tax rate on all types of income is 40%. In Sheridan's December 31, 2025 balance sheet, the ending retained earnings balance is O $4606500. O $5206000. O $3518000. O $4691000